Industry PharmaceuticalsOther
A.I.dvisor tells us that EVO and ESPR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and ESPR's prices will move in lockstep.
Ticker / NAME | Correlation To EVO | 1D Price Change % | ||
---|---|---|---|---|
EVO | 100% | +12.09% | ||
ESPR - EVO | 25% Poorly correlated | -5.83% | ||
EBS - EVO | 24% Poorly correlated | -7.02% | ||
ASRT - EVO | 22% Poorly correlated | -1.88% | ||
COLL - EVO | 21% Poorly correlated | +0.30% | ||
ZTS - EVO | 21% Poorly correlated | -1.36% | ||
More |
Ticker / NAME | Correlation To EVO | 1D Price Change % |
---|---|---|
EVO | 100% | +12.09% |
Pharmaceuticals category (308 stocks) | 10% Poorly correlated | -1.29% |
Pharmaceuticals: Other category (235 stocks) | 10% Poorly correlated | -1.52% |